Cardiology 2024 Highlights and Predictions for 2025

Drs Harrington and Gibson review their picks for the top cardiology trials of 2024 and look ahead to 2025, particularly what health topics may be prioritized by the new administration.
This podcast is intended for healthcare professionals only.
To read a transcript or to comment www.medscape.c...
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction (REDUCE AMI) www.nejm.org/d...
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD) doi.org/10.105...
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis EARLY TAVR www.nejm.org/d...
Asundexian versus Apixaban in Patients with Atrial Fibrillation (OCEANIC-AF) doi.org/10.105...
In the Wake of OCEANIC-AF, Is Equipoise Regarding Factor XI Inhibition Still Afloat? www.jacc.org/d...
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial doi.org/10.101...
Preventive Coronary Stents: Not There Yet
www.medscape.c...
Speech by Commissioner Robert M. Califf to the House of Medicine June 16, 2023
www.fda.gov/ne...
Evolution of Single-Lead ECG for STEMI Detection Using a Deep Learning Approach
doi.org/10.101...
From ST-Segment Elevation MI to Occlusion MI: The New Paradigm Shift in Acute Myocardial Infarction doi.org/10.101...
You may also like:
Hear John Mandrola, MD’s summary and perspective on the top cardiology news each week, on This Week in Cardiology
www.medscape.c...
Questions or feedback, please contact [e-mail]